Notice Concerning Making Renalys Pharma, Inc. A Wholly-Owned Subsidiary
24/10/2025 09:02
Oct 24 (Reuters) - Chugai Pharmaceutical Co Ltd 4519.T: CHUGAI PHARMACEUTICAL CO LTD: NOTICE CONCERNING MAKING RENALYS PHARMA, INC. A WHOLLY-OWNED SUBSIDIARY Source text: ID:nTSvx8d215 Further company coverage: 4519.T (Reporting by Tokyo Newsroom) ((+81345201189;))
Recent news on Chugai Pharmaceutical
See all newsRegarding Discontinuation Of Development Of Gym329 (Emugrobart) For Obesity, Return Of License And Resumption Of Development For SMA
Table: Chugai Pharm 6-MTH group results (IFRS)
Japan's Nikkei roars past 62,000 on earnings, Middle East optimism; JGBs rally (updated)
Japan's Nikkei surges past 61,000 for first time on earnings, Mideast optimism
Japan's Nikkei closes above 60,000 for first time on earnings optimism (updated)